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Abstract
Background: Leptospirosis is a reemerging zoonosis with a worldwide distribution and a wide range of clinical
manifestations. We report a case of leptospirosis meningitis in a previously healthy woman infected by her pet
mouse.
Case presentation: A 27-year-old Caucasian woman with pet mice presented to our institute with a 1 week history
of fever, headache, myalgia, vomiting, diarrhea, and dark urine. Her admission examination revealed neck stiffness,
conjunctivitis, and icteric sclera. Her liver enzymes, bilirubin, white blood cell count, and C-reactive protein were
elevated. Her cerebrospinal fluid showed an elevated white blood cell count. Polymerase chain reactions using her
cerebrospinal fluid, blood, and urine showed negative results for leptospirosis, but the result of her
microagglutination test was positive for Leptospira interrogans serovar sejroe with a more than threefold increase in
paired sera. The patient was treated with ceftriaxone for 1 week, and her condition steadily improved.
Conclusions: This case report raises awareness of pet rodents as sources of leptospirosis. Leptospirosis meningitis
should be considered in patients with meningeal symptoms and pet rodents.
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Background
Leptospirosis is a reemerging zoonosis that occurs
worldwide and is believed to be underdiagnosed because
of challenging diagnostics and a wide clinical spectrum
of disease [1]. The incidence in Europe has recently been
reported to be 0.13 per 100,000 inhabitants [2]. Lepto-
spirosis is caused by Leptospira species, a group of spiro-
chete bacteria [3] with 29 described serogroups and
more than 200 different Leptospira serovars [4]. Leptos-
pira species infect mammals as well as fish, birds, and
reptiles [5]. Infected animals become reservoirs for the
disease, and rodents constitute the most important res-
ervoir [6]. Leptospira species colonize the renal proximal
tubules of their reservoir hosts and are excreted in the
urine [7, 8]. When Leptospira are excreted into the en-
vironment, they are able to survive for several months in
water [9], which constitutes an important source of in-
fection [4]. Humans are usually infected by contact with
urine-contaminated water [10]. Leptospira enter the
human body by penetration of damaged skin or via oral,
genital, or conjunctival mucous membranes, and they
are hematogenously disseminated afterward [11]. Disease
manifestations vary from mild or asymptomatic to severe
illness with multiorgan failure [12]. Patients with lepto-
spirosis typically present with fever, headache, and myal-
gia [11], but symptoms of any organ may be apparent
[10]. Severe forms include meningitis, pulmonary
hemorrhage with respiratory failure, or Weil’s disease
characterized by jaundice, bleeding, and renal failure
[11]. Leptospirosis may mimic other infectious diseases,
such as influenza, viral hepatitis, brucellosis, infectious
mononucleosis, malaria, or dengue, depending on the
setting [10], or even bacterial or viral meningitis [13]. A
recent review on leptospirosis meningitis revealed that
almost all patients (N = 366 adults) presented with fever
(98%), headache (94%), and neck stiffness (93%) [13].
The authors of that review found that the patients’ me-
dian age was 33 years, that most were male, and that the
majority were believed to have acquired the infection
from their work environment, with others contracting it
after contact with fresh water [13]. There were no cases
of transmission from pets. In this report, we describe a
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case of leptospirosis meningitis in a young, previously
healthy woman who was most likely infected by her pet
mouse.
Case presentation
A 27-year-old Caucasian woman with an unremarkable
medical history was admitted to a local hospital because
of 1 week of fever, lower back pain, and cough. Since
her fifth day of disease, she had experienced severe head-
ache, ear and eye pain, and yellowish eyes. Further com-
plaints included nausea, vomiting, dark urine, and
diarrhea with pale stools. The patient had no recent
travel history but had mice as pets, and one had fallen ill
with conjunctivitis 1.5 months prior to the onset of the
patient’s symptoms. Because of the patient’s symptoms
and relevant exposure, leptospirosis and meningitis were
suspected, and she was transferred to the Department of
Infectious Diseases, Copenhagen University Hospital
Rigshospitalet.
On admission, the patient’s physical examination re-
vealed neck stiffness, conjunctivitis, and icteric sclera.
Her blood pressure was 113/65 mmHg, heart rate was
79 beats/minute, temperature was 38.1 °C, respiratory
rate was 16 breaths/minute, and oxygen saturation was
98% without oxygen supplementation. Her laboratory
examination showed an elevated white blood cell count
(WBC) of 12.3 × 109/L and C-reactive protein (CRP) of
198 mg/L, along with increased liver function test values
(alanine aminotransferase 186 U/L, alkaline phosphatase
359 U/L, γ-glutamyl transferase 624 U/L, and bilirubin
50 U/L) and hypoalbuminemia of 27 g/L. The results of
the patient’s abdominal ultrasound and chest radiog-
raphy were both normal. Cerebrospinal fluid (CSF)
showed elevated leukocytes at 213 cells/mm3 (56% poly-
morphonuclear cells), lactic acid at 2.7 mmol/L, glucose
at 3.4 mmol/L, and protein at 0.55 g/L. The result of her
CSF culture was negative. Her blood and urine were ex-
amined on day 7 of disease with polymerase chain reac-
tion (PCR) tests that showed negative results for
leptospirosis. However, the result of her microagglutina-
tion test (MAT) on day 11 of disease was positive and
demonstrated strongest reactivity against Leptospira
interrogans serovar sejroe with antibody titers of 3000,
increasing to 10,000 on day 22 of disease. Conventional
blood cultures were collected before the antibiotic treat-
ment was initiated, but urine culture and lumbar punc-
ture were done after 1 day of treatment. The patient was
initially empirically treated with piperacillin-tazobactam
and then briefly shifted to a bacterial meningitis regimen
with ampicillin and ceftriaxone. Because of suspected
leptospirosis, the patient was treated with 2 g of ceftriax-
one intravenously for 7 days, and her condition im-
proved. After 1 week of hospitalization, the patient was
discharged without any sequelae. Figure 1 illustrates the
antibiotic treatment in relation to CRP level during 1
week of hospitalization.
Discussion
We report a case of leptospirosis meningitis in a previ-
ously healthy young woman who was most likely
Fig. 1 Antibiotic treatment and C-reactive protein during hospitalization
Nordholm et al. Journal of Medical Case Reports          (2019) 13:362 Page 2 of 4
infected by her pet mouse. In a recently published sur-
veillance and outbreak report, six cases of leptospirosis
transmission from pet rodents to humans were retro-
spectively recognized [14]. The median age of the pa-
tients was 31 years, and four of six cases were in women.
One case was meningitis/meningoencephalitis [14]. A
literature review revealed only four previous case reports
about transmission of leptospirosis from pets [15–18],
all of which were cases involving pet rats, and no cases
were of meningitis. Though rare, these cases highlight
the need for awareness of possible leptospirosis trans-
mission from pets.
Leptospirosis has a wide range of disease manifesta-
tions and may mimic many other infectious diseases
[10], which could potentially lead to misdiagnoses or
doctor’s delay. Our patient had disseminated disease
with symptoms arising from several organs. Leptospir-
osis was suspected because the patient had pet mice, and
she was treated according to this suspicion. Prior to the
onset of our patient’s symptoms, one of her pet mice
had fallen ill with conjunctivitis. Unfortunately, the
mouse was killed before being tested for leptospirosis.
The incubation time for leptospirosis is 2–30 days [19],
and the patients typically present with fevers and head-
ache [11], which are also symptoms that could represent
a central nervous system infection. Despite these fre-
quent symptoms, meningitis is present in only around
20% of leptospirosis cases [13, 20]. According to the lit-
erature, leptospirosis meningitis often affects young
adults with no serious concurrent medical diseases, and
the prognosis is usually good [13]. In our patient’s case,
CSF showed elevated WBC with a small predominance
of polymorphonuclear cells, but we were not able to de-
tect Leptospira in CSF by culture or real-time PCR, con-
sistent with the literature [13, 21], nor did we succeed in
detecting leptospires in blood or urine. The timing of
the PCR test is very important for the identification of
leptospires because they are detectable only in the blood
and CSF during the first week and in the urine after 2–3
weeks of disease [10]. We might have conducted testing
too late to detect Leptospira in the patient’s blood and
CSF and too early to detect it in the urine. The advan-
tage of PCR, which is widely used, is that it has both
high sensitivity (100%) and specificity (93%) [12], though
this varies, depending on the specific PCR assay used,
the time when it is used in the disease course, and if it is
used before antibiotics have been initiated. The down-
side of the PCR test is the narrow window of detectabil-
ity in the disease course and the fact that the test does
not provide information on Leptospira serogroup. The
diagnostic “gold standard” is MAT [22], which measures
antibody titers to specific Leptospira serovars [11]. Anti-
bodies are usually not detectable until days 7–10 of dis-
ease [10]. An MAT result is considered positive when
titers are > 100, and, more importantly, the diagnosis is
confirmed if there is an approximately fourfold rise in ti-
ters in paired sera [11]. In our patient’s case, the clinical
diagnosis was substantiated by the positive MAT result.
Challenges regarding current diagnostics probably con-
tribute to the disease’s being underreported, as stated by
the World Health Organization [1]. In addition, sero-
logic studies show much higher seropositive case rates
than reported cases [20]. Only a fraction of patients with
leptospirosis are hospitalized, because many infected in-
dividuals are either asymptomatic or have mild flulike
symptoms, and these cases might not be diagnosed or
reported to the authorities.
Though easily manageable if recognized in time, the
disease can still be lethal, which is why accurate diag-
nostics and proper treatment are essential. The rec-
ommended treatment is intravenous penicillin or
ceftriaxone [23]. Our patient responded well to both
piperacillin-tazobactam and the subsequent week of
ceftriaxone intravenously.
This risk of acquiring leptospirosis from pet rodents
should be followed closely, especially because pet ro-
dents have become more popular over the past few de-
cades [24]. Being a pet rat owner is highly associated
with risk of acquiring leptospirosis [25]. We never found
the source of infection, and how our patient’s mouse
was infected therefore remains unknown. Pet rodents
bought in pet shops should be disease-free, which is why
there may be a future need for screening pets for zoo-
nosis, such as leptospirosis. One minor possible inter-
vention could be to provide informational material
about how to reduce transmission likelihood to new pet
rodent owners, as also suggested by others [14].
Conclusions
This case report underlines that pet rodents may be
sources of leptospirosis. Our findings emphasize that
leptospirosis meningitis should be considered in patients
with meningeal symptoms who have pet rodents.
Obtaining a thorough medical history is essential, in-
cluding information on animal exposure as well as estab-
lishing a timeline of the patient’s symptoms in order to
use the proper diagnostics at the right time.
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